Hot Off the Press: Difficult to Breathe—It Could be Pneumonia
Open Access
- 24 April 2020
- journal article
- editorial
- Published by Wiley in Academic Emergency Medicine
- Vol. 27 (6), 514-516
- https://doi.org/10.1111/acem.13993
Abstract
Biomarkers may help differentiate community‐acquired pneumonia (CAP) from other causes of lower respiratory tract infection. Potentially useful biomarkers in this setting include C‐reactive protein, procalcitonin and white blood cell count, all of which are available in the emergency department as well as in some primary care settings. This systematic review and meta‐analysis evaluates the utility of these biomarkers for diagnosis of outpatient CAP.Keywords
This publication has 5 references indexed in Scilit:
- Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired PneumoniaClinical Infectious Diseases, 2017
- The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population2013
- Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic studyBMJ, 2013
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Does This Patient Have Community-Acquired Pneumonia?JAMA, 1997